ASML Stock Trades at a Discount: Should You Buy, Sell or Hold?

ASML Holding reported robust Q2 2025 results, with net sales growing 23.2% and EPS surging 47.1%, both surpassing analyst estimates. Despite this, the stock declined 9.6% post-earnings, driven by a significantly weaker Q3 revenue guidance (€7.4-€7.9 billion vs. consensus €9.81 billion) and management's retraction of prior 2026 growth projections, citing customer hesitation and U.S.-China tariff discussions. While ASML trades at a P/E discount to peers, this valuation is now perceived as reflecting increased near-term risks rather than a buying opportunity, leading to a 'Sell' recommendation.

Analysis

ASML Holding NV presents a clear disconnect between strong historical performance and a deteriorating forward outlook. The company reported robust second-quarter 2025 results, with net sales increasing 23.2% year-over-year to €7.69 billion and EPS surging 47.1% to €5.90, beating consensus estimates by 1.8% and 12.8% respectively. However, the market reacted negatively, with the stock falling 9.6% post-announcement. This decline is directly attributable to weak third-quarter guidance, which projects revenues between €7.4 billion and €7.9 billion—significantly below the consensus estimate—and a contracting gross margin, expected to fall to 50-52% from 53.7% in Q2. More critically, management has withdrawn its previous confidence in the 2026 growth outlook, now stating it “cannot confirm growth” due to customer hesitation and the impact of U.S.-China tariff discussions. While ASML's forward P/E of 26.14 represents a discount to the tech sector and key peers like NVIDIA and Broadcom, this is increasingly viewed as a reflection of risk rather than a value opportunity. This sentiment is reinforced by the stock's significant year-to-date underperformance (+7.1%) compared to the sector (+13.7%) and the downward revision of the 2026 Zacks Consensus Estimate by 4.1% over the past month.

Key Decisions for Investors

• Investors should treat ASML's valuation discount with caution, as it appears to reflect the market pricing in significant risks from slowing growth momentum and margin compression rather than a simple buying opportunity.
• The weak Q3 revenue and margin guidance, coupled with management's retraction of the 2026 growth outlook, should be considered primary indicators, superseding the strong but backward-looking Q2 earnings report.
• Monitor developments related to U.S.-China tariff policies and customer capital expenditure plans, as these external factors were explicitly cited as key drivers of the increased uncertainty impacting ASML's near-term prospects.
• Given the negative forward guidance, downward earnings revisions, and bearish management commentary, it may be prudent to avoid initiating new positions or consider reducing exposure until there is greater clarity on the 2026 growth trajectory and stabilization in gross margins.